Moderna
MRNA
#1165
Rank
S$21.72 B
Marketcap
$56.46
Share price
0.02%
Change (1 day)
-50.79%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

P/S ratio for Moderna (MRNA)

P/S ratio as of December 2024 (TTM): 3.16

According to Moderna 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.34. At the end of 2024 the company had a P/S ratio of 5.00.

P/S ratio history for Moderna from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.00-10.96%
20235.6153.56%
20223.66-37.03%
20215.81-96.15%
20201519.95%
2019137235.08%
201840.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
4.04 27.90%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 229.42%๐Ÿ‡บ๐Ÿ‡ธ USA
15.1 376.78%๐Ÿ‡บ๐Ÿ‡ธ USA
3.94 24.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
777 24,483.00%๐Ÿ‡บ๐Ÿ‡ธ USA
3.99 26.08%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA